Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,481–3,488 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Redhill Biopharma Ltd. YELIVA (Opaganib) COVID-19 Phase 2/3 Ongoing Oral COVID-19
Redhill Biopharma Ltd. RHB-102 GLP-1/GIP receptor agonist therapy-associated GI side effects Phase 2 Trial Planned Oral Endocrinology
Redhill Biopharma Ltd. Opaganib (ABC294640) Neuroblastoma Phase 2 Ongoing Oral Oncology
Redhill Biopharma Ltd. RHB-107 (upamostat) - (ACESO PROTECT) Early COVID-19 outpatient treatment Phase 2 Ongoing Oral COVID-19
Redhill Biopharma Ltd. Opaganib - (MUSC Trial) Prostate Cancer Phase 2 Ongoing Oral Oncology
Redhill Biopharma Ltd. BEKINDA IBS-D Phase 2 Trial Planned Oral Gastroenterology
Redhill Biopharma Ltd. YELIVA (Opaganib) COVID-19 Phase 2a Trial Completed Oral COVID-19
Redhill Biopharma Ltd. YELIVA (Opaganib) Cholangiocarcinoma Phase 2a Ongoing Oral Oncology